Log in

LON:RBReckitt Benckiser Group Share Price, Forecast & News

GBX 7,446
-82.00 (-1.09 %)
(As of 07/6/2020 08:47 AM ET)
Add
Compare
Today's Range
7,438
Now: GBX 7,446
7,591.80
50-Day Range
6,830
MA: GBX 7,090.40
7,432
52-Week Range
5,130
Now: GBX 7,446
8,191.30
Volume451,834 shs
Average Volume1.72 million shs
Market Capitalization£52.87 billion
P/E RatioN/A
Dividend Yield2.80%
BetaN/A
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; footcare and footwear products; sore throat medications; and women's beauty products under the Nurofen, Scholl, Strepsils, and Veet brand. In addition, the company offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet bowl cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; and fabric washing products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands, as well as infant and child nutrition products under the Enfamil and Nutramigen brands. It operates in the United States, Canada, Europe, Russia/CIS, Turkey, Israel, Australia, New Zealand, and internationally. The company was founded in 1823 and is headquartered in Slough, the United Kingdom.
Read More
Reckitt Benckiser Group logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.7Dividend Strength: 0.8Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.76 out of 5 stars


Industry, Sector and Symbol

Industry Personal Products
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone+44-1753-217800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£12.85 billion
Cash FlowGBX 218.96 per share
Book ValueGBX 1,319.20 per share

Profitability

Miscellaneous

Employees37,345
Market Cap£52.87 billion
Next Earnings Date7/28/2020 (Estimated)
OptionableNot Optionable

Receive RB News and Ratings via Email

Sign-up to receive the latest news and ratings for RB and its competitors with MarketBeat's FREE daily newsletter.

Reckitt Benckiser Group (LON:RB) Frequently Asked Questions

How has Reckitt Benckiser Group's stock been impacted by COVID-19 (Coronavirus)?

Reckitt Benckiser Group's stock was trading at GBX 5,561 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, RB stock has increased by 33.9% and is now trading at GBX 7,446. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Reckitt Benckiser Group?

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Reckitt Benckiser Group in the last year. There are currently 2 sell ratings, 5 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Reckitt Benckiser Group.

When is Reckitt Benckiser Group's next earnings date?

Reckitt Benckiser Group is scheduled to release its next quarterly earnings announcement on Tuesday, July 28th 2020. View our earnings forecast for Reckitt Benckiser Group.

How often does Reckitt Benckiser Group pay dividends? What is the dividend yield for Reckitt Benckiser Group?

Reckitt Benckiser Group declared a dividend on Thursday, February 27th. Stockholders of record on Thursday, April 16th will be given a dividend of GBX 101.60 per share on Thursday, May 28th. This represents a dividend yield of 1.64%. The ex-dividend date of this dividend is Thursday, April 16th. This is a positive change from Reckitt Benckiser Group's previous dividend of GBX 73. The official announcement can be seen at this link. View Reckitt Benckiser Group's dividend history.

What price target have analysts set for RB?

20 brokers have issued 1 year price targets for Reckitt Benckiser Group's shares. Their forecasts range from GBX 4,900 to GBX 9,000. On average, they anticipate Reckitt Benckiser Group's share price to reach GBX 7,154.21 in the next year. This suggests that the stock has a possible downside of 3.9%. View analysts' price targets for Reckitt Benckiser Group.

Has Reckitt Benckiser Group been receiving favorable news coverage?

News stories about RB stock have trended negative on Monday, InfoTrie Sentiment reports. The research group rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Reckitt Benckiser Group earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Reckitt Benckiser Group.

Who are some of Reckitt Benckiser Group's key competitors?

What other stocks do shareholders of Reckitt Benckiser Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Reckitt Benckiser Group investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Athabasca Oil (ATH), Chipotle Mexican Grill (CMG), Prudential (PRU), NIC (EGOV), Aegean Marine Petroleum Network (ANW), Centrica (CNA) and British American Tobacco Plc Ads (BATS).

Who are Reckitt Benckiser Group's key executives?

Reckitt Benckiser Group's management team includes the following people:
  • Mr. Rakesh Kapoor, CEO & Exec. Director (Age 60)
  • Mr. Adrian Nevil Hennah, CFO & Exec. Director (Age 62)
  • Mr. Seth Cohen, Chief Information Officer
  • Mr. Richard Joyce, Sr. VP of Investor Relations
  • Mr. Rupert Bondy, Sr. VP, Gen. Counsel & Company Sec. (Age 57)

What is Reckitt Benckiser Group's stock symbol?

Reckitt Benckiser Group trades on the London Stock Exchange (LON) under the ticker symbol "RB."

How do I buy shares of Reckitt Benckiser Group?

Shares of RB and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Reckitt Benckiser Group's stock price today?

One share of RB stock can currently be purchased for approximately GBX 7,446.

How big of a company is Reckitt Benckiser Group?

Reckitt Benckiser Group has a market capitalization of £52.87 billion and generates £12.85 billion in revenue each year. Reckitt Benckiser Group employs 37,345 workers across the globe.

What is Reckitt Benckiser Group's official website?

The official website for Reckitt Benckiser Group is www.rb.com.

How can I contact Reckitt Benckiser Group?

Reckitt Benckiser Group's mailing address is 103-105 Bath Road, SLOUGH, SL1 3UH, United Kingdom. The company can be reached via phone at +44-1753-217800.

This page was last updated on 7/6/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.